Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction - ARMYDA-6 MI

Description:

The goal of the trial was to evaluate pretreatment with clopidogrel 600 mg compared with 300 mg among patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).